HEALTH ECONOMIC EVALUATION OF PRESERVATIVE-FREE TAFLUPROST VERSUS PRESERVED LATANOPROST IN THE TREATMENT OF OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION (OH)

被引：1
|
作者：
Makino, K. [1 ]
Charles, H. [2 ]
Tilden, D. [1 ]
Cottrell, S. [1 ]
Mudge, M. [1 ]
Christova, L. [1 ]
Van Bavel, J. [2 ]
West, B. [2 ]
Woodgate, A. M. [2 ]
机构：
[1] THEMA Consulting Pty Ltd, Pyrmont, NSW, Australia
[2] Merck Sharp & Dohme Australia Pty Ltd, N Ryde, NSW, Australia
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.242
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A643 / A643
页数：1
相关论文
共 50 条
  • [1] Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
    Aptel, Florent
    Choudhry, Reena
    Stalmans, Ingeborg
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1457 - 1463
  • [2] Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension
    Swymer, Cory
    Neville, Michael W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1506 - 1510
  • [3] A REVIEW OF PRESERVED AND PRESERVATIVE-FREE PROSTAGLANDIN ANALOGUES FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    Hommer, A.
    [J]. DRUGS OF TODAY, 2010, 46 (06) : 409 - 416
  • [4] Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
    Chabi, A.
    Baranak, C.
    Lupinacci, R.
    Herring, W. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (07) : 577 - 586
  • [5] Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension
    Mark Sanford
    [J]. Clinical Drug Investigation, 2014, 34 : 521 - 528
  • [6] Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension
    Sanford, Mark
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 521 - 528
  • [7] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Paul Harasymowycz
    Cindy Hutnik
    Jean-François Rouland
    Francisco J. Muñoz Negrete
    Mario A. Economou
    Philippe Denis
    Christophe Baudouin
    [J]. Advances in Therapy, 2021, 38 : 3019 - 3031
  • [8] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Harasymowycz, Paul
    Hutnik, Cindy
    Rouland, Jean-Francois
    Negrete, Francisco J. Munoz
    Economou, Mario A.
    Denis, Philippe
    Baudouin, Christophe
    [J]. ADVANCES IN THERAPY, 2021, 38 (06) : 3019 - 3031
  • [9] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Carl Erb
    Ines Lanzl
    Seid-Fatima Seidova
    Friedemann Kimmich
    [J]. Advances in Therapy, 2011, 28
  • [10] 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
    Konstas, Anastasios-Georgios
    Boboridis, Konstadinos G.
    Kapis, Paraskevas
    Marinopoulos, Konstantinos
    Voudouragkaki, Irini C.
    Panayiotou, Dimitrios
    Mikropoulos, Dimitrios G.
    Pagkalidou, Eirini
    Haidich, Anna-Bettina
    Katsanos, Andreas
    Quaranta, Luciano
    [J]. ADVANCES IN THERAPY, 2017, 34 (01) : 221 - 235
12345